Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2444) 2444
Newsletter (47) 47
Book Chapter (19) 19
Newspaper Article (11) 11
Magazine Article (8) 8
Transcript (7) 7
Book / eBook (4) 4
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1712) 1712
humans (1670) 1670
life sciences & biomedicine (1595) 1595
microbiology (912) 912
infectious diseases (811) 811
anti-bacterial agents - pharmacology (759) 759
microbial sensitivity tests (743) 743
anti-bacterial agents - therapeutic use (718) 718
beta lactamases (696) 696
pharmacology & pharmacy (696) 696
beta-lactamases - metabolism (579) 579
female (574) 574
antibiotics (554) 554
beta-lactamases - genetics (550) 550
male (544) 544
beta-lactamase inhibitors (534) 534
biological and medical sciences (517) 517
medical sciences (464) 464
drug resistance (388) 388
pharmacology. drug treatments (379) 379
middle aged (377) 377
bacteria (373) 373
antibacterial agents (371) 371
health aspects (358) 358
antibiotics. antiinfectious agents. antiparasitic agents (357) 357
drug resistance in microorganisms (356) 356
adult (345) 345
aged (335) 335
animals (282) 282
beta-lactamases - biosynthesis (264) 264
research (250) 250
infections (228) 228
antimicrobial agents (225) 225
escherichia coli - drug effects (225) 225
e coli (221) 221
drug resistance, bacterial (218) 218
escherichia coli (216) 216
enterobacteriaceae - drug effects (214) 214
biochemical phenomena, metabolism, and nutrition (211) 211
bacterial proteins - genetics (208) 208
klebsiella pneumoniae - drug effects (205) 205
analysis (203) 203
enzymes (203) 203
research article (203) 203
aged, 80 and over (200) 200
risk factors (200) 200
drug resistance, multiple, bacterial (194) 194
beta-lactam resistance (192) 192
hospitals (191) 191
pneumonia (191) 191
polycyclic compounds (191) 191
enterobacteriaceae infections - microbiology (188) 188
infectious disease (188) 188
beta-lactamase inhibitors - therapeutic use (187) 187
antibiotic resistance (184) 184
bacterial infections - drug therapy (179) 179
enterobacteriaceae - enzymology (179) 179
bacterial infections and mycoses (178) 178
escherichia coli - enzymology (175) 175
penicillanic acid - analogs & derivatives (174) 174
bacterial proteins - metabolism (171) 171
treatment outcome (169) 169
klebsiella infections - microbiology (168) 168
carbapenems - pharmacology (164) 164
adolescent (161) 161
epidemiology (158) 158
klebsiella pneumoniae - enzymology (158) 158
retrospective studies (152) 152
gram-negative bacteria - drug effects (151) 151
medicine (150) 150
β-lactamase (150) 150
pseudomonas aeruginosa (149) 149
escherichia coli infections - microbiology (148) 148
genes (146) 146
penicillanic acid - therapeutic use (145) 145
carbapenems (144) 144
cephalosporins (144) 144
enterobacteriaceae infections - drug therapy (143) 143
pseudomonas aeruginosa - drug effects (143) 143
klebsiella infections - drug therapy (141) 141
nosocomial infections (140) 140
cephalosporins - therapeutic use (139) 139
drug therapy, combination (139) 139
mortality (139) 139
bacterial pneumonia (136) 136
carbapenemase (136) 136
carbapenems - therapeutic use (135) 135
cross infection - microbiology (135) 135
klebsiella pneumoniae - isolation & purification (135) 135
immunology (134) 134
laboratories (134) 134
internal medicine (133) 133
escherichia coli - isolation & purification (132) 132
escherichia coli - genetics (131) 131
polymerase chain reaction (130) 130
enterobacteriaceae (129) 129
beta-lactams - pharmacology (127) 127
urinary tract infections (127) 127
beta-lactamases - chemistry (126) 126
antimicrobial resistance (125) 125
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2458) 2458
Japanese (23) 23
German (21) 21
French (19) 19
Spanish (18) 18
Russian (17) 17
Italian (10) 10
Portuguese (9) 9
Polish (4) 4
Chinese (3) 3
Dutch (2) 2
Afrikaans (1) 1
Czech (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text New β-lactamase inhibitors: A therapeutic renaissance in an MDR world
by Drawz, Sarah M and Papp-Wallace, Krisztina M and Bonomo, Robert A
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 2014, Volume 58, Issue 4, pp. 1835 - 1846
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Azabicyclo Compounds - pharmacology | Humans | Enzyme Inhibitors - pharmacology | Gram-Negative Bacterial Infections - drug therapy | Enzyme Inhibitors - therapeutic use | Gram-Negative Bacteria - enzymology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Drug Resistance, Multiple, Bacterial | Azabicyclo Compounds - therapeutic use | Anti-Bacterial Agents - pharmacology | beta-Lactamase Inhibitors | Index Medicus | Minireview
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Risks of Cardiac Arrhythmia and Mortality Among Patients Using New-Generation Macrolides, Fluoroquinolones, and β-Lactam/β-Lactamase Inhibitors: A Taiwanese Nationwide Study
by Hsu-Wen Chou and Jiun-Ling Wang and Chia-Hsuin Chang and Chao-Lun Lai and Mei-Shu Lai and K. Arnold Chan
Clinical infectious diseases, ISSN 1058-4838, 2/2015, Volume 60, Issue 4, pp. 566 - 577
ARTICLES AND COMMENTARIES | ventricular arrhythmia | cardiovascular death | azithromycin | levofloxacin | moxifloxacin | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Arrhythmias, Cardiac - epidemiology | Arrhythmias, Cardiac - chemically induced | Arrhythmias, Cardiac - mortality | Comorbidity | Ciprofloxacin - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Logistic Models | Male | Risk | Clarithromycin - therapeutic use | Fluoroquinolones - adverse effects | Anti-Bacterial Agents - therapeutic use | Azithromycin - adverse effects | beta-Lactamase Inhibitors - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Azithromycin - therapeutic use | beta-Lactamase Inhibitors - therapeutic use | Taiwan | Cardiovascular Diseases - mortality | Levofloxacin - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Levofloxacin - adverse effects | Taiwanese | Treatment outcome | Arrhythmia | Mortality | Macrolide antibiotics | Risk factors | Quinolones | Analysis | Beta lactam antibiotics | Quinolone antibacterial agents | Dosage and administration | Drug therapy | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections
by Papp-Wallace, Krisztina M
Expert opinion on pharmacotherapy, ISSN 1465-6566, 11/2019, Volume 20, Issue 17, pp. 2169 - 2184
β-lactamase inhibitor | Antimicrobial resistance | β-lactam | β-lactamase | Gram-negative | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Tazobactam - chemistry | Humans | Cephalosporins - chemistry | Gram-Negative Bacterial Infections - drug therapy | Boronic Acids - chemistry | Clinical Trials as Topic | Boronic Acids - therapeutic use | Meropenem - therapeutic use | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Heterocyclic Compounds, 1-Ring - chemistry | Tazobactam - therapeutic use | beta-Lactamase Inhibitors - therapeutic use | Heterocyclic Compounds, 1-Ring - therapeutic use | Meropenem - chemistry | Drug Combinations | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text β-Lactam/β-Lactamase Inhibitor Combinations
: From Then to Now
by Toussaint, Kimberly A and Gallagher, Jason C
1/2015, Volume 49, Issue 1, 13
MK-7655 | relebactam | clavulanate | bacterial resistance | tazobactam | avibactam | RPX7009 | β-lactamase inhibitor | carbapenemase | β-lactamase | sulbactam | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Anti-Bacterial Agents - therapeutic use | Humans | beta-Lactamase Inhibitors - therapeutic use | Bacterial Proteins - metabolism | beta-Lactamases - metabolism | Drug Therapy, Combination | beta-Lactams - therapeutic use | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Ceftazidime-avibactam: A novel cephalosporin/β-lactamase inhibitor combination
by Zhanel, George G and Lawson, Christopher D and Adam, Heather and Schweizer, Frank and Zelenitsky, Sheryl and Lagacé-Wiens, Philippe R. S and Denisuik, Andrew and Rubinstein, Ethan and Gin, Alfred S and Hoban, Daryl J and Lynch III, Joseph P and Karlowsky, James A
Drugs (New York, N.Y.), ISSN 0012-6667, 02/2013, Volume 73, Issue 2, pp. 159 - 177
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Azabicyclo Compounds - pharmacology | Bacterial Infections - drug therapy | Ceftazidime - pharmacology | Humans | Clinical Trials as Topic | Azabicyclo Compounds - chemistry | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Anti-Bacterial Agents - chemistry | Ceftazidime - chemistry | Azabicyclo Compounds - therapeutic use | Anti-Bacterial Agents - pharmacology | beta-Lactamase Inhibitors | Drug Therapy, Combination | Ceftazidime - therapeutic use
Journal Article
Details down arrow
6. Full Text Can We Really Use ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ß-Lactamase-Producing Bacteria?
by Federico Perez and Robert A. Bonomo
Clinical infectious diseases, ISSN 1058-4838, 1/2012, Volume 54, Issue 2, pp. 175 - 177
Enzymes | Health outcomes | Infectious diseases | Antibiotics | Microbiology | Escherichia coli | Bacteria | Infections | ARTICLES AND COMMENTARIES | Carbapenems | Dosage | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Escherichia coli Infections - drug therapy | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Humans | Bacteremia - drug therapy | Penicillanic Acid - therapeutic use | Female | Male | beta-Lactamase Inhibitors | Penicillanic Acid - analogs & derivatives | Piperacillin - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
by Rodríguez-Baño, Jesús and Navarro, María Dolores and Retamar, Pilar and Picón, Encarnación and Pascual, Álvaro and Estudio Infeccion Hosp Grp and Extended-Spectrum Beta-Lactamases–Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group
Clinical infectious diseases, ISSN 1058-4838, 2012, Volume 54, Issue 2, pp. 167 - 174
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Multivariate Analysis | beta-Lactam Resistance | Prospective Studies | Escherichia coli - drug effects | Humans | Middle Aged | Male | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Aged, 80 and over | Penicillanic Acid - therapeutic use | Female | beta-Lactamase Inhibitors | Penicillanic Acid - analogs & derivatives | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Bacteremia - drug therapy | Proportional Hazards Models | Escherichia coli Infections - microbiology | Escherichia coli Infections - epidemiology | Escherichia coli - isolation & purification | Spain - epidemiology | Bacteremia - epidemiology | Aged | Piperacillin - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens
by Bush, Karen
International journal of antimicrobial agents, ISSN 0924-8579, 2015, Volume 46, Issue 5, pp. 483 - 493
Infectious Disease | Carbapenemase | ESBL | β-Lactam | Gram-negative | MBL | β-Lactamase inhibitor | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Gram-Negative Bacteria - enzymology | Gram-Negative Bacterial Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Drug Therapy, Combination - methods | Humans | beta-Lactamase Inhibitors - therapeutic use | Drug Discovery - trends | Gram-Negative Bacterial Infections - epidemiology | Clinical Trials as Topic | beta-Lactams - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights